News

Biocon Biopharmaceuticals, a joint venture between Biocon and Cimab SA, has rights to the drug from Cimab for the Indian subcontinent. In other markets, including Europe, North America,

Under the terms of the agreement, Beijing Med-Pharm will serve as the exclusive distributor of Anpo (ritodrine hydrochloride), a treatment for preterm labor, in mainland China. Beijing Med-Pharm

The Generic Pharmaceutical Association (GPhA) said the measure will close another loophole that needlessly delays generic entry into the market. The association claims this tactic has been used

MultiCell, which develops therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, raised $1.7 million in gross proceeds in a private placement

The Roche-supported study, named PERSIST, involved 103 primary care centers across the UK, with 1,076 women each agreeing to participate for a six-month period. In the study, 542

A review of 12 studies carried out by the Cochrane Collaboration found that a 1.5g dose of calcium by mouth during the second half of pregnancy significantly reduced

The fast track designation for Nexavar (sorafenib) tablets in advanced (including locally unresectable and metastatic) melanoma means Bayer and Onyx will be able to file a new drug

The delay is due to the fact that Pfizer wants to introduce Exubera after conducting a comprehensive physician and patient education and training program. To further support patients

Under the terms of the agreement, Amgen has the right to develop drug candidates it has identified from Infinity’s compound collection. Infinity received an upfront license fee from